ALFA News
Straight from the exchange filing
Every announcement Sun Pharmaceutical Industries has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Every Sun Pharmaceutical Industries announcement on ALFA FilingsSee filings →Reference market data from a third-party provider, as of the most recent story. Not a valuation or a recommendation.
Sun Pharmaceutical Industries Ltd receives US FDA approval for ILUMYA in adults with active psoriatic arthritis, expanding its specialty dermatology portfolio.
Sun Pharma partners with LIB Therapeutics for global licensing of Lerodalcibep, targeting a US$3.7 billion PCSK9 inhibitor market excluding the US and China.
